Skip to content
★ Sign in to follow
황

황을문

Executive
Chairman & CEO
미래에셋생명서린바이오서린바이오
Total declarations
9
Companies
2
▲ Purchases (9 ops.)
€80k
▼ Sales (0 ops.)
—

Latest filing published 02 Apr 2026 for 서린바이오.

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 02 Apr 2026 · 220 days ago
    -28.2%
    Entry ₩6,100 · Close at T+90 ₩4,378
  • Filed 28 Mar 2023 · 1321 days ago
    -24.9%
    Entry ₩11,086 · Close at T+365 ₩8,325
  • Filed 21 May 2021 · 1997 days ago
    -48.5%
    Entry ₩20,660 · Close at T+365 ₩10,649
  • Filed 02 Apr 2021 · 2046 days ago
    +4.9%
    Entry ₩13,060 · Close at T+365 ₩13,698

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

황을문: trading record in brief

황을문, listed as chief executive, has filed trades across 2 companies (mainly through DART (FSS)), most often in 서린바이오 and 미래에셋생명. Between 2 April 2021 and 26 March 2026, the trades on record add up to 9 filings.

Every open-market trade on record is a purchase: 9 purchases worth €80k, and no sale. The amount is not disclosed for 8 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and no sales on the market.

Clusters matter here: 1 out of 8 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 2 April 2026: an open-market purchase, in 서린바이오. The median gap between a trade and its publication by DART (FSS) is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 황을문

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20260402001073
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20230328000302
    Canonical exit: 26 Jun 2023 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20230328000299
    Canonical exit: 26 Jun 2023 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20230328000301
    Canonical exit: 26 Jun 2023 (T+90)
  • ▲
    Executives미래에셋생명
    0DART
    26,708 sharesShareKRXDART:20220401002326
    Canonical exit: 26 Jun 2022 (T+90)
  • ▲
    Executives서린바이오
    0DART
    56,670 sharesShareKRXDART:20220323000411
    Canonical exit: 16 Jun 2022 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20210521000368
    Canonical exit: 19 Aug 2021 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20210402001133
    Canonical exit: 1 Jul 2021 (T+90)
  • ▲
    대표이사/회장Executives(filed)서린바이오
    0DART
    ShareKRXDART:20210402001150
    Canonical exit: 1 Jul 2021 (T+90)

9 of 9 declarations